Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET)
Clinical trial NCT04350216 · UNKNOWN
Trial details
- NCT number
- NCT04350216
- Sponsor
- Instituto de Investigación Marqués de Valdecilla
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2020-10-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.